All the events here are relevant to people working in dementia research. If you would like to add your own you can submit an event
- This event has passed.
BioNow Neuroscience Conference
17/07/2024 @ 9:00 am - 5:00 pm
Accelerating Diagnosis and Treatment of Neurological Diseases
Introducing the inaugural Bionow Neuroscience conference, created to bring together academics, clinicians and industry experts in the spirit of collaboration & growth.
The conference aims to highlight the strengths in the discovery, development and commercialisation of neuroscience treatments and technologies across North England and beyond. The event will showcase key developments across neuroscience, including a range of neurological diseases and conditions such as Alzheimer’s disease, cerebal palsy, dementia, epilepsy, Huntington’s disease, motor neurone disease (MND) and Parkinson’s disease.
Why attend?
The Bionow Neuroscience Conference will explore the current challenges and opportunities facing Neuroscience, highlighting new approaches that will create opportunities for R&D, commercialisation and implementation plus will consider the impact on patient outcomes.
Bringing the expertise, funding and new technologies together in the neuroscience field is one of the biggest challenges facing the Life Sciences sector and society at large. The aim of this conference is to bring together all these elements and contribute to the eradication of these diseases.
Programme
09:00 Conference Welcome
09:05 Keynote
Professor Dame Pamela Shaw, Director of the Sheffield Institute for Translational Neuroscience, University of Sheffield
09:30 State of the Nation Panel
Chair: Kevin Cox, Non-Executive Director, British Neuroscience Association
Laura Ajram, CEO, British Neuroscience Assocation
Heather Mortiboys, Professor of Cellular Neuroscience and Metabolism, University of Sheffield
Shadi Farhangrazi, CEO & Co-founder, SM Discovery Group
Tatiana Rosenstock, Principle Scientist in Vitro Neuroscience, Sygnature Discovery
10:30 Tea, Coffee & Networking
11:00 Early Diagnosis and Detection
Dale Athey, CEO, ESP Diagnostics
Oliver Bandmann, Professor of Movement Disorders Neurology, University of Sheffield
Tom Foltynie, Professor of Neurology in Department of Clinical and Movement Neurosciences, UCL Institute of Neurology
12:00 Treatments of the future and Where are we now?
Andy Whiting, CEO, Nevrargenics
Paul Chazot, Professor of Pharmacology, Durham University
Ruth Roberts, Co-founder of Apconix and Professor at University of Birmingham
Moein Moghimi, Co-founder of S.M. Discovery Group
Farid Khan, CEO, PharmaKure
13:30 Lunch
14:40 Keynote 2
Fiona Menzies, Associate Vice President and Head of Proteostasis, Eli Lily
15:05 Funding and Investment Panel
Sara Imarisio,Strategy Leader for Neuroscience, Medicine Discovery Catapult
Sara Rodrigues, Senior Research Manager, ARUK
Arthur Roach, Director, Parkinson’s UK Virtual Biotech
Jenny Barnett, CEO, Monument Therapeutics
Henning Steinhagen, CEO, Epidarex Exeed & CEO, Lario Therapeutics
